Exam 2, deck 3 Flashcards
most common age groups for VTE
neonates and teenagers
most common precipitating factor in VTE
Central venous access device (CVAD)
Anticoagulation in symptomatic and asymptomatic deep vein thrombosis or pulmonary embolism
- The American Society of Hematology (ASH) guideline panel recommends using anticoagulationin pediatric patients with symptomatic deep vein thrombosis (DVT) or pulmonary embolism (PE) (
- The ASH guideline panel suggests either using anticoagulation or no anticoagulation in pediatric patients with asymptomatic DVT or PE
Thrombolysis, thrombectomy, and inferior vena cava filters in VTE
- against using thrombolysis followed by anticoagulation; rather, anticoagulation alone should be used in pediatric patients with DVT, submassive PE
2.The ASH guideline panel suggests using thrombolysis followed by anticoagulation, rather than anticoagulation alone, in pediatric patients with PE with hemodynamic compromise
3.suggests against using thrombectomy followed by anticoagulation; rather, anticoagulation alone should be used in pediatric patients with symptomatic DVT or PE
- suggests against using inferior vena cava (IVC) filter; rather anticoagulation alone should be used in pediatric patients with symptomatic DVT or PE
Antithrombin replacement therapy in VTE
- The ASH guideline panel suggests against using antithrombin (AT)-replacement therapy in addition to standard anticoagulation; rather, standard anticoagulation alone should be used in pediatric patients with DVT/cerebral sino venous thrombosis (CSVT)/PE
- ASH guideline panel suggests using AT replacement therapy in addition to standard anticoagulation rather than standard anticoagulation alone in pediatric patients with DVT/CSVT/PE who have failed to respond clinically to standard anticoagulation treatment and in whom subsequent measurement of AT concentrations reveals low AT levels based on age-appropriate reference ranges
CVAD-related thrombosis
- suggests no removal, rather than removal, of a functioning CVAD in pediatric patients with symptomatic CVAD-related thrombosis who continue to require venous access
2, removal, rather than no removal, of a nonfunctioning or unneeded CVAD in pediatric patients with symptomatic CVAD-related thrombosis
- suggests delayed removal of a CVAD until after initiation of anticoagulation (days), rather than immediate removal in pediatric patients with symptomatic central venous line–related thrombosis who no longer require venous access or in whom the CVAD is nonfunctioning
- ASH guideline panel suggests either removal or no removal of a functioning CVAD in pediatric patients who have symptomatic CVAD-related thrombosis with worsening signs or symptoms, despite anticoagulation and who continue to require venous access
Use of Low-molecular-weight heparin vs vitamin K antagonists in DTE
The ASH guideline panel suggests using either low-molecular-weight heparin or vitamin K antagonists in pediatric patients with symptomatic DVT or PE (conditional recommendation based on very low certainty in the evidence of effects
what happens in DIC
hemostasis is out of control
leading to coagulation all over the place
leads to organ ischemia
This uses up platelets and clotting factors
Other parts of body start to bleed even with slight damage of walls.
They have too much and too little clotting
Fibrin degradation products in circulation interferes with clot formation making hemostasis even more difficult
DIC is also called
consumption coagulopathy
Lab findings in DIC
decreased platelets
decreased fibrinogen
prolonged PT/PTT
elevated D Dimer (fibrin degradation product)
Treatment DIC
support organs with
-Ventilator
-Hemodynamic
-Transfusions
all if needed
fever/neutropenia def by megan harvey
A single temp of 38.3C (101) or
2 episodes of 38 (100.4) and above within a 24 hr period
or
Temp of 39C (100.4) persistent for one hour taken axillary orally or by tympanic probe
ANC formula by meg harvey
WBC x (%segs +%bands)
ANC <1500 neutropenia
ANC <1000 moderate neutropenia
ANC <500 severe neutropenia
ANC <100-200 profound neutropenia
When is ANC typically at lowest
7-14 days from start of round of chemo
common infection culprits in febrile neutropenia
Gram + Bacteria - coag neg staph. Staph aureus, strepto viridans and midas
Gram - Bacteria, enterobacter, pseudomonas
Anaerobic Bacteria - Clostr dificille, propionbacterum acnes
Fungus
Viruses- hsv varicella zoster, ebv, cmv, ect
others - pjp
what studies do you avoid in febrile neutropenia
lumbar puncture
tap shunt or reservoir
Abx in febrile neutropenia
Monotherapy
-Cefepime 50mg/kg IV q 8
-Meropenem 20-40 mg/kg IV q8
-Zosyn 80-100 mg/kg IV q8
Dual therapy
-Ceftazidime 33-50mg/kg IV q 8 and
Tobramycin 7.5 mg/kg/day IV q8 or 7-9mg/kg IV Q24
(monitor trough levels weekly with aminoglycoside administration due to nephron and ototoxicity)
Anaerobes
-Clindamycin 40mg/kg IV q6 (aspiration pneumonia)
-Flagyl 7.5mg/kg IV q6
-give flagyl if concern for abd infection, typhlitis, perianal or mucosal skin breakdown
Add Vanc if
-AmL receiving high dose Cytarabine (Ara-C) with risk of S.viridans due to interruption of mucosal integrity and risk of sepsis
-hypotensive or have signs of shock
-Mucositis
-Prior h/o alpha hemolytic strep bacteremia
-Concern for catheter site infection or skin breakdown
-Colonized with resistant organisms only sensitive to vancomycin
-Cardiac vegitations
(At risk for tox, monitor trough levels with goal of 10-15 for bacteremia, 15-20 for meningitis)
(at risk for impaired renal function, monitor renal function, electrolytes and fluid balance daily)
Vanc trough level goal for bacteremia and meningitis
10-15 for bacteremia
15-20 for meningitis
when should you cover for fungal in fever neutropenia
fever persists for >1 week
When you have a fever neutropenia pt who you are going to cover for fungal, what to order first
fungal blood culture
serum galactomannan
consider ENT consult for eval of sinuses with flexible scope
CT of sinuses, chest and/or abdomen to evaluate for fungal nodes
antifungal agents in fever neutropenia
Echinocandins - covers most candida and at least fungistatic to Aspergillus. Empiric fungal agents of choice.
-Micafungin
-Caspofungin
-Anidulafungin
Triazoles - Fungicidal to Aspergillus. If clinically worsening
-Fluconazole
-Voriconazole
-Posaconazole
Amphotericin B
-Significant toxicity potential (nephrotoxic)
-Lipid formulation (Ambisome) has less side effects, but is more expensive
HSV and VZV require treatment with
IV acyclovir
Valacyclovir
Famciclovir
If hemoc has VZV how does effect treatment
cessation of chemotherapy administration
labs to monitor when give Acyclovir
nephrotoxic - monitor renal function and fluid intake closely
CMV in hemonc pt, treat with
Ganciclovir
if persistent infection or resistant - transition to Foscarnet or Cidofovir
Hemonc with influenza requires treatment with
Oseltamivir
Most effective if given within 48 hrs of symptom onset
Can be given prophylaxis if exposed to virus
Considered an atypical fungus, causes severe pneumonitis in immunocompromised patients
Pneumocystis Jiroveci
Pneumocystis Jiroveci diagnosis
confirmed by testing induced sputum, lower resp culture
Bronchoalveolar lavage sample
percutaneous needle or open lung biopsy
Pneumocystis Jiroveci prophylaxis in fever neutropenia
Bactrim
Pentamidine
consider addition of corticosteroid
in fever neutropenia, continue appropriate antimicrobials until pt
remained afebrile for at least 24 hours, negative blood cultures from admission for 48 hours, has neg blood cultures providing clearance of infection and with rising ANC demonstrating appropriate bone marrow recovery
Bone marrow recovery - ANC of >200 and rising on 2 consecutive CBCs
Resolution of neutropenia is ANC >500
type A blood has what AB in Plasma and what antigens on RBCs
AB in plasma: Anti-B
Antigens: A antigen
type B blood has what AB in Plasma and what antigens on RBCs
AB in plasma: Anti-A
Antigens: B antigen
type AB blood has what AB in Plasma and what antigens on RBCs
AB in plasma: None
Antigens in RBC: A and B
type O blood has what AB in Plasma and what antigens on RBCs
AB in plasma: Anti-A and Anti-B
Antigens on RBC: none
life threatening disease of bone marrow failure resulting in peripheral pancytopenia and bone marrow aplasia
Aplastic anemia
causes of aplastic anemia
congenital in 20%
Acquired - exposure to drugs, chemicals, ionizing radiation or viruses
s/s of aplastic anemia
History: mucosal/gingival bleeding, headaches, fatigue, easy bruising, rash, fever, mucosal ulcerations, or recurrent viral infections. *
Symptoms: pallor, tachycardia, petechial rash, purpura, ecchymoses, or jaundice.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (pp. 785-786). Wolters Kluwer Health. Kindle Edition.
what do labs show in aplastic anemia
*Decrease in hemoglobin, white blood cell (WBC) count, and platelet count.
*Reduction in or absence of the absolute number of reticulocytes.
* Peripheral blood smear; no abnormal cells.
*Reduction or absence of hematopoietic elements from bone marrow aspirate.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 786). Wolters Kluwer Health. Kindle Edition.
mgmt of aplastic anemia
- Transfusions of RBCs and platelets.
- Antibiotic therapy.
- Bone marrow transplantation (BMT).
*Immunosuppressive therapy if unable to receive a BMT.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 786). Wolters Kluwer Health. Kindle Edition.
A rare congenital hypoplastic anemia resulting in constitutional bone marrow failure.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 786). Wolters Kluwer Health. Kindle Edition.
Diamond-Blackfan Anemia
Mutation for Diamond-Blackfan on chromosome
19 which encodes for a ribosomal protein known as RPS19
s/s Diamond Blackfan anemia
*Symptoms: pallor, fatigue, irritability, syncope, and dyspnea during feeding.
*Physical examination: irregular heartbeat, hypotonia, short stature, and evidence of failure to thrive.
*Associated with physical defects including craniofacial, hands, upper limbs, cardiac, or genitourinary.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 787). Wolters Kluwer Health. Kindle Edition.
Diamond Blackfan Anemia is associated with what type of physical defects
craniofacial, hands, upper limbs, cardiac, or genitourinary.
what do labs look like in Diamond Blackfan Anemia
*Profound macrocytic anemia; WBCs and platelet count generally normal.
* Reticulocytopenia.
* Increased percentage of hemoglobin F for age.
* Elevated erythrocyte adenosine deaminase activity. *Decreased or absent erythroid precursors in bone marrow aspirate.
* Genetic screening; Diamond–Blackfan anemia—mutation in RPS19.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 787). Wolters Kluwer Health. Kindle Edition.
management in Diamond Blackfan Anemia
*Corticosteroids, frequent blood transfusion, BMT in some cases.
* Hematology, BMT, and endocrinology team involvement.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 787). Wolters Kluwer Health. Kindle Edition.
An enzyme that is crucial in aerobic glycolysis
Glucose-6-phosphate Dehydrogenase Deficiency (G6PD)
Children who have G6PD-deficient RBCs are susceptible to
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 805). Wolters Kluwer Health. Kindle Edition.
oxidative damage and hemolysis during certain conditions of stress, exposure to certain medications, foods, or chemicals. Occurs most often in males.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 805). Wolters Kluwer Health. Kindle Edition.
G6PD deficiency is most common in what gender
males
which variant?
G6PD activity is less than 10% of normal, resulting in severe neonatal jaundice or congenital nonspherocytic hemolytic anemia.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 805). Wolters Kluwer Health. Kindle Edition.
Variant 1
G6PD activity is typically less than 30% of the normal range, resulting in an asymptomatic steady state. Individuals who carry this mutation are at risk for neonatal jaundice, acute hemolytic anemia, and favism.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 805). Wolters Kluwer Health. Kindle Edition.
variant 2
which variant?
G6PD Enzyme activity is greater than 85% of the normal reference range, resulting in no clinical manifestations. Considered the “wild type” disease.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 805). Wolters Kluwer Health. Kindle Edition.
Variant 3
G6PD is a ___ linked inherited disease that affects primarily ___
X-linked inherited disease that affects primarily men.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 805). Wolters Kluwer Health. Kindle Edition.
G6PD is an enzyme required for the production of the reduced form of ____________ which __
Nicotinamide adenine dinucleotide Phosphate (NADPH) which is critical in preventing oxidative damage
In G6PD deficiency acute exacerbations may occur with ingestion of ____ and what else
fava beans (Favism)
infection
Oxidative drugs ( antimalarials, sulfa containing drugs, ASA, quinolones)
s/s G6PD deficiency
Symptoms: fever, nausea, abdominal pain, diarrhea, and occasionally vomiting within 24 to 48 hours after oxidative challenge. *Findings: Dark brown or black discoloration of the urine is present within 6 to 24 hours after exposure (result of hemolysis); jaundice, pallor, tachycardia, hypovolemic shock, and hepatosplenomegaly may develop.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 806). Wolters Kluwer Health. Kindle Edition.
lab findings for G6PD deficiency
severe anemia with marked variation in size of RBCs resulting in increase in RBC distribution width
WBC may be elevated
Hemoglobinuria may be present
*Large polychromatic cells with spherocytic morphology as well as markedly irregular-shaped cells known as poikilocytes on peripheral blood smear. *Increased reticulocyte count; may reach levels as high as 30%. *Heinz body stain: As the RBCs circulate through the spleen, Heinz bodies are removed, resulting in classic “bite cells.” Heinz bodies are identified with methyl violet staining and are denatured hemoglobin and a manifestation of the oxidative injury to the hemoglobin.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 806). Wolters Kluwer Health. Kindle Edition.
Mgmt G6PD def
*Blood transfusion is indicated if the child is hemodynamically unstable or the hemoglobin level declines to <7g/dL.
*If the hemoglobin is <9 g/dL with evidence of persistent brisk hemolysis with hemoglobinuria, blood transfusion may be indicated.
*Dialysis may be indicated for acute kidney failure.
*Neonatal jaundice related to G6PD deficiency is managed with observation for mild cases, phototherapy, and hydration for more significant cases, and exchange transfusion may be beneficial for severe cases.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (pp. 806-807). Wolters Kluwer Health. Kindle Edition.
An acute, systematic, immune complex mediated, small-vessel vasculitis, which is self-limiting and resolves within about 4 weeks, considered the most common vasculitis of childhood.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 801). Wolters Kluwer Health. Kindle Edition.
Henoch-Schonlein Purpura
most common vasculitis of childhood
Henoch-Schonlein Purpura
Peak age presentation in Henoch-Schonlein Purpura
2-8
what months is it more common to see Henoch-Schonlein Purpura
fall, winter and spring
most serious complication of Henoch-Schonlein Purpura
Renal impairment
Henoch-Schonlein Purpura is usually precipitated by
an URI, medication or environmental trigger
what infectious agents associated with Henoch-Schonlein Purpura
Group A strep
what happens in Henoch-Schonlein Purpura
IgA complexes are deposited in the small vessels of the renal glomeruli, skin and GI tract causing petechiae, purpura, GI bleeding and Glomerulonephritis
s/S Henoch-Schonlein Purpura
*Recent upper respiratory tract infection and prodrome of fever and fatigue.
* Commonly presents with tetrad of symptoms:
*Rash: nonpruritic, erythematous papules or wheals that progress to petechiae, and nonblanching, palpable, purpuric lesions >10 mm diameter; found in dependent areas of body that are subject to pressure and extensor surfaces of the extremities. Trunk is usually spared, and lesions fade over 10 to 12 days.
- Polyarthralgias: pain, swelling, decreased range of motion; Lower extremity joints most frequently involved.
- “Bowel angina” - diffuse, colicky abdominal pain with melena and vomiting; approximately 70% of patients.
- Renal symptoms with hematuria, proteinuria, and hypertension; approximately 20–60 % of patients weeks to months after initial presentation
- Mild renal impairment may progress to nephrotic syndrome and ARF.
- Renal biopsy consistent with focal and proliferative glomerulonephritis.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (pp. 801-802). Wolters Kluwer Health. Kindle Edition.
lab findings in Henoch-Schonlein Purpura
*Based on clinical features and presenting symptoms; renal function should be evaluated at baseline. * Platelets normal or elevated. * BUN and creatinine may be elevated. * Normal coagulation studies. *Immune antibody panel—Presence of IgA antibodies in the blood, skin, or glomeruli may help to confirm diagnosis. * Urinalysis for evaluation of blood and protein.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 802). Wolters Kluwer Health. Kindle Edition.
management of Henoch-Schonlein Purpura
*Rest and activity limitations, with symptomatic management of systemic complications, NSAIDS.
*Oral prednisone; indicated for patients with kidney involvement.
*Henoch-Schönlein purpura resulting in severe kidney disease may require plasma exchange, high-dose IV immunoglobulin (IVIG), or immunosuppressant agents.
* Long-term management of hypertension may be required.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (pp. 802-803). Wolters Kluwer Health. Kindle Edition.
a disease of the microcirculation, is characterized by hemolytic anemia, thrombocytopenia, and acute renal failure (ARF).
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 791). Wolters Kluwer Health. Kindle Edition.
Hemolytic Uremic Syndrome (HUS)
Hemolytic Uremic Syndrome (HUS) occurs most frequently in what age
children <4 years
Most common cause of acute renal failure
Hemolytic Uremic Syndrome (HUS)
what causes Hemolytic Uremic Syndrome (HUS)
*Contamination of water, meat, fruits, and vegetables with infectious bacteria; peak incidence during summer.
*E. coli 0157:H7 is the most common etiology of postdiarrheal (D+) HUS.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 791). Wolters Kluwer Health. Kindle Edition.
types of HUS
*D+ HUS—Postdiarrheal or typical HUS; occurs in previously healthy children who have had recent gastroenteritis. Mortality rate is 3% to 5%; associated with renal failure in 50% to 70% of patients affected. Bacterial verotoxins, absorbed through intestinal mucosa, are produced by E. coli O157:H7 infection (Shiga toxin; most common cause), Shigella dysenteriae, Citrobacter freundii, and other subtypes of E. coli (also Shiga toxin).
*D−HUS—Atypical or sporadic HUS is less common and more severe than D+HUS with an approximately 25% mortality rate. It is associated with end-stage renal disease in approximately 50% of cases. More common in adulthood, atypical D−HUS infection may have a familial link and may also begin in the neonatal period; occurs year round with no gastrointestinal (GI) prodrome. Causative factors include Inherited factor H deficiency (10%–20%); inhibits complement activation, Membrane cofactor protein mutations, Streptococcus pneumoniae infection, medications including Cyclosporine and Tacrolimus.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (pp. 791-792). Wolters Kluwer Health. Kindle Edition.
what does ESR and CRP look like in Oligo, poly and systemic JIA
They can be normal in Oligo
Poly may be mildly elevated
systemic will be more elevated
racoon eyes, abd discomfort, no trauma…what should you be thinking
neuroblastoma
butterfly or malar rash, think
Systemic lupus erythematosus
s/s Systemic lupus erythematosus
Photosensitivity - rash in reaction to sunlight
oral ulcers - usually painless
Nonerosive arthritis
Serositis (pleuritis)
Renal disorder (persistent proteinuria)
Seizures
Anemia, leukopenia, lymphopenia
main worry after BMT
Graft vs host disease
if suspecting Lupus (SLE), but ANA comes back negative. How likely is it to still be Lupus
Very unlikely positive in 99%
Anti-dsDnA is used at time of diagnosis and beyond for Lupus (SLE), why?
to monitor disease activity
C3 and C4 in Lupus (SLE)
low or undetectable during a flair
Anti Smith antibody is highly specific fof
Lupus (SLE) positive in 50% . not used to monitor disease activity
SSA or SSb Ab in Neonatal lupus erythematosus causes destruction to what
conductive system of the heart. Typically leads to congenital heart block. 30-50% of these babies will need a pacemaker
what is the mother given during pregnancy in suspected neonatal Lupus erythematosus
Dexamethasone for Fetal bradycardia to prevent further destruction of conductive system of heart
After birth in neonatal lupus erythematosus, what is the prognosis
most will need a pacemaker
they may have rash or other lupus symptoms
usually all symptoms resolve except heart block approx 6 months later
Video source: lupus (SLE) medication management
Hydroxychloroquine
corticosteroids
Cyclophosphamide (Cytoxan)
Other immunosuppressive agents
NSAIDS
Calcium (due to corticosteroids)
vitamin D (due to corticosteroids)
inflammation of sacroiliac joints (SI) and the axial skeleton
Ankylosing Spondylitis (AS) and Spondyloarthropathy
Ankylosing Spondylitis (AS) and Spondyloarthropathy s/s
Low back pain that is worse in the morning and improves with exercise
expected lab findings in Ankylosing Spondylitis (AS) and Spondyloarthropathy
High ESR and CRP
Positive HLA B27 (helps support dx but not required)
Radiology findings for Ankylosing Spondylitis (AS) and Spondyloarthropathy
Sacroiliitis with sclerosis
Bamboo sign: Bridging syndesmophytes
Bamboo sign on x ray
Ankylosing Spondylitis (AS) and Spondyloarthropathy
clinical presentation of sjogren syndrome
recurrent parotitis
keratoconjunctivitis sicca (more common in adults)
Keratoconjunctivitis sicca is chronic, bilateral desiccation of the conjunctiva and cornea caused by too little tear production or accelerated tear evaporation. Typical symptoms include intermittent itching; burning; blurring, a gritty, pulling, or foreign body sensation; and photosensitivity.
Labs to pay attention to in Sjogren syndrome
Anti-Ro (SS-A) or Anti-La (SS-B)
management of sjogren syndrome
Artificial tears
Pilocarpine tablets
Antimalarial for skin rash and arthritis
sjogren syndrome is associated with r/o
lymphoma
infections associated with reactive arthritis
GI infections
-shigella
-salmonella
-yersinia
-Campylobacter
-C.Diff
GU infections
-UTIS, ect
reactive arthritis is developed _____-___ weeks after infection
2-4
reactive arthritis is usually in how many joints
more than one but can be only one
typical triad s/s of reactive arthritis
Noninfectious urethritis
Arthritis
Conjunctivitis
expected labs in reactive arthritis
elevated ESR and CRP
HLA-B27 positive in 65-96% (helps support case but doesnt rule in or rule out)
treatment for reactive arthritis
supportive care
JDM s/s
muscle pain and weakness
Skin rash
-photosensitivity
-Gottron papules
-Heliotrope rash
Calcinosis cutis
labs to look for in JDM
Elevated CK level
Treatment in JDM
Prednisone
Sun voidance
Hydroxychloroquine
s/s systemic scleroderma
pruritic skin
Raynaud’s phenomenon
difficulty swallowing
shortness of breath
Joint pain and limitation of movement
weakness
lab to look for in systemic scleroderma
Positive SCL 70 (topoisomerase) in 2/3 of pt
pruritic skin
Raynaud’s phenomenon
difficulty swallowing
shortness of breath
Joint pain and limitation of movement
weakness
systemic scleroderma
muscle pain and weakness
Skin rash
-photosensitivity
-Gottron papules
-Heliotrope rash
Calcinosis cutis
JDM
recurrent parotitis
keratoconjunctivitis sicca (more common in adults)
Sjogren syndrome
target sign on US
what can it be seen in?
(they have a rash)
intussusception - can be seen in HSP
s/s in localized scleroderma
Streak involve the face En coup de Sabre
seizure
Uveitis
Treatment in localized scleroderma
mainly supportive
physical therapy if joints resolve
Streak involve the face En coup de Sabre
seizure
Uveitis
localized scleroderma
Prognosis in localized scleroderma
resolve spontaneously within 3-4 years
Behcet’s disease diagnostic criteria
recurrent oral ulcers 3 times over 1 year
+ at least 2 of the following
-Recurrent genital ulceration
-eye inflammation
-Characteristic skin lesions
-positive pathergy test
Treatment for Behcet’s disease (video)
Azathioprine
or
Infliximab
test to confirm Behcet’s disease
Pathergy test
- Pathergy test, in which your doctor inserts a sterile needle into your skin and examines the area one to two days later. If the test is positive, a small red bump forms under your skin where the needle was inserted. This indicates your immune system is overreacting to a minor injury
most common vasculitis in children
Henoch-Schonlein purpura (HSP)
s/s in Henoch-Schonlein purpura (HSP)
purpura
arthritis
GI
-abd pain
-GI bleeding
Nephritis
subcutaneous edema
scrotal edema
purpura
arthritis
GI
-abd pain
-GI bleeding
Nephritis
subcutaneous edema
scrotal edema
Henoch-Schonlein purpura (HSP)
diagnosis for Henoch-Schonlein purpura (HSP)
clinical diagnosis
Platelet count may be normal or elevated (if low, suggests different diagnosis)
occult blood may positive
ESR can be elevated
Screen for blood or protein in urine
In Henoch-Schonlein purpura (HSP) what do you monitor and for how long
Monitor for at least 6 months even if initial was normal
proteinuria
BP for HTN
treatment for Henoch-Schonlein purpura (HSP)
Supportive (hydration , NSAIDS)
Corticosteroid (controversial) however consider in:
-persistent nephrotic syndrome
-severe abd pain
-severe scrotal edema
-neurologic system involvement
Immunosuppressive in complicated cases
d/c causative drug
diagnostic criteria for Kawasaki disease (video)
Fever lasts longer than 5 days plus
4/5 of following main clinical features
-changes in peripheral extremities (redness, edema of hands and feet, followed by desquamation)
-polymorphous rash
-oropharyngeal changes
-bilat, nonexudative, painless bulbar conjunctival injection (redness in both eyes without discharge)
-acute non-purulent cervical lymphadenopathy with lymph node diameter greater than 1.5cm, usually unilateral
common associated symptoms of KD
Hydrops of gallbladder
d/v
abd pain
irritability
vomiting alone
cough or rhinorrhea
decreased intake
weakness
joint pain
echo protocols in KD (video)
at time of dx
repeat in 2nd week
again 1 month after all labs have normalized
1 year if at 8 week no coronary involvement
Refer to pediatric cardiologist at anytime if echo is abnormal
labs suggestive of KD
no specific lab test to dx
CRP >= 3 or ESR >=40
WBC >= 15000
Normocytic, normochromic anemia
Pyuria: >= 10 wbc (clean catch instead of cath is better, can miss the pyuria if collected by cath)
Serum ALT >50
Serum albumin <= 3.0 g/DI
After 7 days of illness, platelet cell count >= 450,000
tx for KD (video)
IVIG (withing first 10 days of illness)
-2g/kg infusion over 12-14 hrs
-watch for anaphylaxis and aseptic meningitis
-relieves acute inflammation to decrease risk of C. aneurysm
Oral ASA
-80 -10mg/kg/day until fever resolves
-decrease to 3-5mg/kg/day if fever resolved and stop if no cardiac involvement after 6-8 weeks
IVIG and ASA have a synergistic effect and gives antiplatelet activity
you can also give corticosteroids
s/s growing pain
diagnosis of exclusion
believed to be a type of stress injury
bilat extremity pain
intermittent pain
pain occurs during evening
can wake from sleep
resolves by morning
does not limit during the day
occurs after days of significant activity
diagnosis of exclusion
believed to be a type of stress injury
bilat extremity pain
intermittent pain
pain occurs during evening
can wake from sleep
resolves by morning
does not limit during the day
occurs after days of significant activity
growing pain
treatment for growing pain
reassurance
Ice
heat
massage
NSAID
s/s reflex sympathetic dystrophy
chronic pain syndrome
pain affect one or more limb
often result of trauma or surgery
limb becomes swollen, red, mottled, warm, cold, sweaty (sympathetic reflex)
-pain is usually out of proportion of touch (hyperalgesia)
diagnosis of reflex sympathetic dystrophy
clinical dx
Affected area may show demineralization on x ray
less uptake on bone scan
treatment in reflex sympathetic dystrophy
aggressive physical therapy
Gabapentin or
Amitriptyline
s/s Familial Mediterranean Fever (MEFV)
periodic fever
severe abd pain
Pleuritis
Pericarditis
scrotal swelling
Erysipelas-like rash may appear around ankle
arthritis, arthralgia, myalgia
key points: periodic fever + pain +/- family history
Familial Mediterranean Fever (MEFV) is autosomal
recessive
Complications of Familial Mediterranean Fever (MEFV)
Amyloidosis leads to proteinuria and renal failure
dx of Familial Mediterranean Fever (MEFV)
clinical dx
can be supported by genetic testing but not excluded by it
ESR, CRP, WBC usually elevated during attack
Treatment for Familial Mediterranean Fever (MEFV)
Colchicine
PFAPA stands for
Periodic fever
Aphthous Stomatitis
Pharyngitis
Cervical Adenitis
Age for PFAPA
6 mos - 7 years
Periodic fevers in PFAPA usually last how many days
5-7 days
In PFAPA, fever cycles usually stops by what age
Teenage years
Treatment for PFAPA (video)
NSAID
single dose of steroids
tonsillectomy
Periodicity for PFAPA is usually how long
less than 4 weeks
painful muscle
weakness
facial rash
elevated ck
dermatomyositis
painful, swollen knee joints,
limited rom for 8 weeks
all other exams and labs are normal
ESR and CRP normal
Oligoarticular JIA
rash worse on sun exposure
joint pain
chest pain
fatigue
anemia
SLE
4 year old boy
bilat leg pain at night
no pain in the morning
physical exam is normal
very active
growing pain
recurrent pain oral ulcers for the last 2 years
deterioration of vision
skin rash
Behcet’s disease
Recurrent fever
abd pain
scrotal swelling
rash on both ankles
elevated ESR
in between attacks ESR is normal
Negative MEFV
FMF
encompasses a complex group of disorders comprising several clinical entities with the common feature of arthritis.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 1347). Wolters Kluwer Health. Kindle Edition.
Juvenile Idiopathic Arthritis
*JIA is a ________disorder, and the subtypes have varying clinical and laboratory features that may reflect distinct immunopathogenic processes.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 1347). Wolters Kluwer Health. Kindle Edition.
heterogeneous
labs in JIA (lippincott)
antinuclear antibody (ANA), rheumatoid factor, and anti–cyclic citrullinated peptide; a positive ANA test does not confirm a diagnosis of JIA but may be prognostic for uveitis.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 1349). Wolters Kluwer Health. Kindle Edition.
what category of drugs are used in JIA
Anti-inflammatory drugs: corticosteroids—oral and intra-articular injections.
* Immunomodulatory therapy with disease-modifying antirheumatic drugs.
* Tumor necrosis factor α inhibitors.
* Interleukin (IL) inhibitors.
* T-cell- and B-cell-targeted therapy.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 1349). Wolters Kluwer Health. Kindle Edition.
A small- to medium-vessel vasculitis.
Kline, Andrea M.; Haut, Catherine. Lippincott Certification Review: Pediatric Acute Care Nurse Practitioner (p. 1350). Wolters Kluwer Health. Kindle Edition.
KD
Joint pain only
arthralgia
When you call something Arthritis you should be using objective findings such as
Joint effusion
Warmth
reduced range of motion
+/- pain
usually not erythema
(dr muscal talk)
inflammation of tendon
tendonitis